Form S-1 Better Therapeutics,
- Wall Street rallies, capping frenetic week with best day of the year
- Apple (AAPL) Stock Soars on Another Robust Quarter Fueled by Monster iPhone and Services Numbers, Analysts Raise PTs
- BofA Raises Inflation Forecasts for 2022, Expects Fed to Hike 7 Times in 2022
- Netflix (NFLX) CEO Hastings Buys ~$20 Million in Stock Following Sell-Off, Ackman's Big Bet
- Oil hits 7-year peak on political risks, supply crunch
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
November 26, 2021
Better Therapeutics, Inc.
548 Market St #49404
San Francisco, CA 94104
Re: Securities Registered under Registration Statement on Form S-1
Ladies and Gentlemen:
We have acted as counsel to you in connection with your filing of a Registration Statement on Form S-1 (as amended or supplemented, the Registration Statement) pursuant to the Securities Act of 1933, as amended (the Securities Act), relating to the registration by Better Therapeutics, Inc., a Delaware corporation (the Company) of up to 20,406,908 shares (the Selling Stockholder Shares) of the Companys common stock, $0.0001 par value per share, to be sold by the selling stockholders listed in the Registration Statement under Selling Stockholders (the Selling Stockholders).
We have reviewed such documents and made such examination of law as we have deemed appropriate to give the opinions set forth below. We have relied, without independent verification, on certificates of public officials and, as to matters of fact material to the opinions set forth below, on certificates of officers of the Company.
The opinion set forth below is limited to the Delaware General Corporation Law.
Based on the foregoing, we are of the opinion that the Selling Stockholder Shares have been duly authorized and validly issued and are fully paid and non-assessable.
We hereby consent to the inclusion of this opinion as Exhibit 5.1 to the Registration Statement and to the references to our firm under the caption Legal Matters in the Registration Statement. In giving our consent, we do not admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations thereunder.
Very truly yours,
|/s/ GOODWIN PROCTER LLP|
Independent Registered Public Accounting Firms Consent
We consent to the inclusion in this Registration Statement of Better Therapeutics, Inc. (f/k/a Mountain Crest Acquisition Corp. II) on Form S-1 of our report dated March 30, 2021, with respect to our audit of the financial statements of Mountain Crest Acquisition Corp. II (now known as Better Therapeutics, Inc.) as of December 31, 2020 and for the period from July 31, 2020 (inception) through December 31, 2020, which report appears in the Prospectus, which is part of this Registration Statement. We were dismissed as auditors on November 22, 2021 and, accordingly, we have not performed any review or audit procedures with respect to any financial statements appearing in the prospectus for the periods after the date or our dismissal. We also consent to the reference to our Firm under the heading Experts in such Prospectus.
/s/ Marcum LLP
New York, NY
November 26, 2021
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Registration Statement on Form S-1 of Better Therapeutics, Inc. (formerly Mountain Crest Acquisition Corp. II) of our report dated March 19, 2021, relating to the financial statements of Better Therapeutics OpCo, Inc. (formerly Better Therapeutics, Inc.), as of and for the years ended December 31, 2019 and December 31, 2020 appearing elsewhere in this Registration Statement.
We also consent to the reference of our firm under the heading Experts in such Registration Statement.
|/s/ Elliott Davis, LLC|
|Greenville, South Carolina|
|November 26, 2021|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Humacyte (HUMA) Announces Preclinical Results of Small-Diameter Human Acellular Vessel in Coronary Artery Bypass Grafting
- Rocket Lab USA, Inc. (RKLB) Selected to Provide Venture Class Launch Services for NASA
- Better Therapeutics to Participate in Two Upcoming Investor Events
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!